Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations

Eye

Volumn 25, Issue 5, 2011, Pages 596-602

  Yu Wai Man, P ^a,b,c   Bailie, M ^b   Atawan, A ^b   Chinnery, P F ^a,c   Griffiths, P G ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

dominant optic atrophy; mitochondrial DNA; OPA1; optical coherence tomography; retinal ganglion cells

Indexed keywords

PEPTIDES AND PROTEINS; PROTEIN OPA1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT OPTIC ATROPHY; CASE STUDY; CELL LOSS; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE MUTATION; HUMAN; NERVE FIBER; NEUROMUSCULAR DISEASE; OBSERVATIONAL STUDY; OPTIC NERVE ATROPHY; OPTICAL COHERENCE TOMOGRAPHY; PRESCHOOL CHILD; PROSPECTIVE STUDY; RETINA GANGLION CELL; RETINA NERVE CELL; RETINAL NERVE FIBRE LAYER THICKNESS; SCHOOL CHILD; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

EID: 79956005877     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.2     Document Type: Article

References (30)

1. Newman NJ, Biousse V. Hereditary optic neuropathies. Eye 2004; 18: 1144-1160. (Pubitemid 39591797)
2. Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J MedGenet 2009; 46: 145-158.
3. Ferre M, Amati-Bonneau P, Tourmen Y, Malthièry Y, Reynier P. eOPA1: an online database for OPA1 mutations. Hum Mutat 2005; 25: 423-428.
4. Ferre M, Bonneau D, Milea D, Chevrollier A, Verny C, Dollfus H et al. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum Mutat 2009; 30: E692-E705.
5. Yu-Wai-Man P, Griffiths PG, Burke A, Sellar PW, Clarke MP, Gnanaraj L et al. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology 2010; 117: 1538.
6. Yu-Wai-Man P, Shankar SP, Biousse V, Miller NR, Bean LJ, Coffee B et al. Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies. Ophthalmology 2010 (e-pub ahead of print 29 October 2010; doi:10.1016/j.ophtha.2010.07.029).
7. Votruba M, Moore AT, Bhattacharya SS. Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy. J Med Genet 1998; 35: 793-800. (Pubitemid 28431696)
8. Cohn AC, Toomes C, Hewitt AW, Kearns LS, Inglehearn CF, Craig JE et al. The natural history of OPA1-related autosomal dominant optic atrophy. Br J Ophthalmol 2008; 24: 24.
9. Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010; 133: 771-786.
10. Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissière A et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy plus phenotypes. Brain 2008; 131: 338-351. (Pubitemid 351197609)
11. Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008; 131: 329-337. (Pubitemid 351197604)
12. Subei AM, Eggenberger ER. Optical coherence tomography: another useful tool in a neuro-ophthalmologist's armamentarium. Curr Opin Ophthalmol 2009; 20: 462-466.
13. Sakata LM, DeLeon-Ortega J, Sakata V, Girkin CA. Optical coherence tomography of the retina and optic nerveFa review. Clin Exp Ophthalmol 2009; 37: 90-99.
14. Budenz DL, Fredette MJ, Feuer WJ, Anderson DR. Reproducibility of peripapillary retinal nerve fiber thickness measurements with stratus OCT in glaucomatous eyes. Ophthalmology 2008; 115: 661-666.
15. Medeiros FA, Zangwill LM, Alencar LM, Bowd C, Sample PA, Susanna Jr R et al. Detection of glaucoma progression with stratus OCT retinal nerve fiber layer, optic nerve head, and macular thickness measurements. Invest Ophthalmol Vis Sci 2009; 50: 5741-5748.
16. Henderson APD, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, Plant GT et al. An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2008; 131: 277-287.
17. Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 2008; 4: 664-675.
18. Talman LS, Bisker ER, Sackel DJ, Long Jr DA, Galetta KM, Ratchford JN et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010; 67: 749-760.
19. Rebolleda G, Munoz-Negrete FJ. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci 2009; 50: 5197-5200.
20. Holladay JT. Proper method for calculating average visual acuity. J Refract Surg 1997; 13: 388-391. (Pubitemid 27369067)
21. Savini G, Barboni P, Valentino ML, Montagna P, Cortelli P, De Negri AM et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Ophthalmology 2005; 112: 127-131. (Pubitemid 40075331)
22. Barboni P, Savini G, Valentino ML, Montagna P, Cortelli P, De Negri AM et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 2005; 112: 120-126. (Pubitemid 40075330)
23. Johnston PB, Gaster RN, Smith VC, Tripathi RC. Clinicopathologic study of autosomal dominant optic atrophy. Am J Ophthalmol 1979; 88: 868-875. (Pubitemid 10236334)
24. Kjer P, Jensen OA, Klinken L. Histopathology of eye, optic-nerve and brain in a case of dominant optic atrophy. Acta Ophthalmol 1983; 61: 300-312. (Pubitemid 13137064)
25. Votruba M, Thiselton D, Bhattacharya SS. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy. Br J Ophthalmol 2003; 87: 48-53. (Pubitemid 36071778)
26. Kim TW, Hwang JM. Stratus OCT in dominant optic atrophyFfeatures differentiating it from glaucoma. J Glaucoma 2007; 16: 655-658.
27. Ito Y, Nakamura M, Yamakoshi T, Lin J, Yatsuya H, Terasaki H. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations. Invest Ophthalmol Vis Sci 2007; 48: 4079-4086. (Pubitemid 351261032)
28. Milea D, Sander B, Wegener M, Jensen H, Kjer B, Jørgensen TM et al. Axonal loss occurs early in dominant optic atrophy. Acta Ophthalmol 2010; 88: 342-346.
29. Chauhan DS, Marshall J. The interpretation of optical coherence tomography images of the retina. Invest Ophthalmol Vis Sci 1999; 40: 2332-2342. (Pubitemid 29418389)
30. Lenaers G, Reynier P, ElAchouri G, Soukkarieh C, Olichon A, Belenguer P et al. OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol 2009; 41: 1866-1874.